| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MIRATI THERAPEUTICS INC COM | 757,935 | 16,220,000 | 15.87% | ||
| 2 | BLUEPRINT MEDICINES CORP COM | 705,159 | 12,728,000 | 12.46% | ||
| 3 | BEIGENE LTD | 416,879 | 12,219,000 | 11.96% | ||
| 4 | CELATOR PHARMACEUTICALS INC | 835,408 | 9,215,000 | 9.02% | ||
| 5 | SEATTLE GENETICS INC | 233,600 | 8,197,000 | 8.02% | ||
| 6 | INCYTE | 100,000 | 7,247,000 | 7.09% | ||
| 7 | Aquinox Pharmaceuticals Inc | 820,015 | 7,233,000 | 7.08% | ||
| 8 | BIOMARIN | 70,000 | 5,774,000 | 5.65% | ||
| 9 | ARADIGM CORP COM | 1,101,513 | 4,891,000 | 4.79% | ||
| 10 | Syndax Pharmaceuticals Inc | 234,220 | 3,120,000 | 3.05% | ||
| 11 | KURA ONCOLOGY INC | 645,685 | 2,615,000 | 2.56% | ||
| 12 | AVEXIS INC COM | 83,276 | 2,268,000 | 2.22% | ||
| 13 | VITAE PHARMACEUTICALS INC | 315,025 | 2,089,000 | 2.04% | ||
| 14 | AKARI THERAPEUTICS PLC | 139,899 | 1,959,000 | 1.92% | ||
| 15 | Nabriva Therapeutics AG | 176,710 | 1,583,000 | 1.55% | ||
| 16 | EIGER BIOPHARMACEUTICALS INC | 93,331 | 1,565,000 | 1.53% | ||
| 17 | ZOGENIX INC | 168,000 | 1,552,000 | 1.52% | ||
| 18 | SOPHIRIS BIO INC | 546,088 | 786,000 | 0.77% | ||
| 19 | NEXVET BIOPHARMA PUB LTD CO | 154,840 | 511,000 | 0.50% | ||
| 20 | ALDEYRA THERAPEUTICS INC | 63,146 | 265,000 | 0.26% | ||
| 21 | ESSA Pharma | 28,100 | 91,000 | 0.09% | ||
| 22 | OncoGenex Pharmaceuticals Inc | 87,827 | 60,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017634, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
